Argatroban: Update
- 1 June 2006
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 151 (6), 1131-1138
- https://doi.org/10.1016/j.ahj.2005.09.002
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- A prospective comparison of three argatroban treatment regimens during hemodialysis in end-stage renal diseaseKidney International, 2004
- Pharmacokinetics and Pharmacodynamics of Argatroban in Combination With a Platelet Glycoprotein IIB/IIIA Receptor Antagonist in Patients Undergoing Percutaneous Coronary InterventionThe Journal of Clinical Pharmacology, 2004
- Argatroban Anticoagulation in Patients With Acute Ischemic Stroke (ARGIS-1)Stroke, 2004
- Failure of argatroban anticoagulation during off-pump coronary artery bypass surgeryThe Annals of Thoracic Surgery, 2004
- Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: effects on prothrombin time, activated partial thromboplastin time, and Ecarin Clotting TimeThrombosis and Haemostasis, 2004
- Extension of the Therapeutic Window for Recombinant Tissue Plasminogen Activator With Argatroban in a Rat Model of Embolic StrokeStroke, 2001
- Novastan®(Brand of Argatroban): A Small-Molecule, Direct Thrombin InhibitorSeminars in Thrombosis and Hemostasis, 1997
- Effect of the Thrombin Inhibitor Argatroban in Acute Cerebral ThrombosisSeminars in Thrombosis and Hemostasis, 1997
- Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectorisJournal of the American College of Cardiology, 1993
- Persistent inhibition of arterial thrombosis by a 1-hour intravenous infusion of argatroban, a selective thrombin inhibitorCoronary Artery Disease, 1992